INNOCRIN PHARMACEUTICALS INC has a total of 26 patent applications. It increased the IP activity by 350.0%. Its first patent ever was published in 2010. It filed its patents most often in Australia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are KOCHI MUTSUYUKI, BIOPROJET SOC CIV and CONFLUENCE LIFE SCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Taiwan | 3 | |
#5 | United States | 2 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | EAPO (Eurasian Patent Organization) | 1 | |
#9 | Japan | 1 | |
#10 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Hoekstra William J | 16 |
#2 | Schotzinger Robert J | 16 |
#3 | Rafferty Stephen William | 11 |
#4 | Eisner Joel | 8 |
#5 | Woodson Elizabeth | 6 |
#6 | Baskin-Bey Edwina | 6 |
#7 | Rafferty Stephen W | 3 |
#8 | Sharp Matthew | 2 |
#9 | Bindl Martin F | 1 |
#10 | William J Hoekstra | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020077197A1 | Compositions for the treatment of brain tumors | |
WO2019182743A1 | Compositions for the treatment of brain tumors | |
AU2018380155A1 | Compositions for the treatment of breast and prostate cancer | |
WO2019113312A1 | Anticancer compound process | |
EP2651905A2 | Metalloenzyme inhibitor compounds | |
AU2011320565A1 | Metalloenzyme inhibitor compounds | |
AU2010339508A1 | Metalloenzyme inhibitor compounds |